Friday, 9 June 2017
Top pharma cos have raised their R&D budget to stay relevant: Sameer Baisiwala, Morgan Stanley
Talking to Ajaya Sharma of ET Now, Sameer Baisiwala, Morgan Stanley , says the new game in town is a plus-plus business model. On top of what you were doing earlier, you have to add extremely complex products. Pharma stocks are showing some resurgence. What is your view on that?
You can read more here: Top pharma cos have raised their R&D budget to stay relevant: Sameer Baisiwala, Morgan Stanley
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment